CEACAM5 and neoplasm: The incidence of colorectal adenocarcinoma has been steadily decreasing following the improvement of diagnostic and therapeutic strategies; reduction of exposure to social risk factors; and monitoring of CEA, carbohydrate antigen 72-4, CA 19-9, and other tumor markers [59].